Singapore markets close in 2 hours 37 minutes

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
11.72-0.15 (-1.26%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 513.02B
Enterprise value 338.09B
Trailing P/E 2,930.00
Forward P/E 14.44
PEG Ratio (5 yr expected) 11.46
Price/sales (ttm)0.78
Price/book (mrq)0.93
Enterprise value/revenue 32.27
Enterprise value/EBITDA 68.21

Trading information

Stock price history

Beta (5Y monthly) 1.58
52-week change 368.61%
S&P500 52-week change 317.36%
52-week high 313.76
52-week low 36.07
50-day moving average 311.99
200-day moving average 311.12

Share statistics

Avg vol (3-month) 39.43M
Avg vol (10-day) 310.82M
Shares outstanding 51.1B
Float 1.09B
% held by insiders 10.60%
% held by institutions 154.67%
Shares short (30 Jul 2020) 421.51M
Short ratio (30 Jul 2020) 42.88
Short % of float (30 Jul 2020) 4N/A
Short % of shares outstanding (30 Jul 2020) 42.06%
Shares short (prior month 29 Jun 2020) 421.87M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 311 Dec 2017
Ex-dividend date 426 Nov 2017
Last split factor 22:1
Last split date 330 Jun 2004

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Jun 2020


Profit margin 0.02%
Operating margin (ttm)18.06%

Management effectiveness

Return on assets (ttm)3.31%
Return on equity (ttm)-1.03%

Income statement

Revenue (ttm)16.79B
Revenue per share (ttm)15.36
Quarterly revenue growth (yoy)-7.30%
Gross profit (ttm)7.54B
Net income avi to common (ttm)4M
Diluted EPS (ttm)0.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.4B
Total cash per share (mrq)2.19
Total debt (mrq)26.68B
Total debt/equity (mrq)179.96
Current ratio (mrq)1.09
Book value per share (mrq)12.64

Cash flow statement

Operating cash flow (ttm)1.44B
Levered free cash flow (ttm)2.31B